ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0997

Geographic and Lifestyle Exposures in Systemic Lupus Erythematosus

Zoe Reed1, Janis Campbell2, Xana Howard1, Teresa Aberle1, Bridget Parrish1, Wade DeJager3, Cristina Arriens1, Joan Merrill4 and Judith James1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City, 4Oklahoma Medical Research Foundation, Oklahoma City 73104, OK

Meeting: ACR Convergence 2024

Keywords: Disparities, Environmental factors, population studies, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) has a complex etiology with genetic predispositions interacting with environmental factors. Extensive environmental exposure information is now publicly available based on geocode. This study examined the relationship between the residential locations of SLE patients participating in the Oklahoma Cohort of Rheumatic Diseases and geocode-specific information about environmental and lifestyle exposures.

Methods: SLE prevalence rates were calculated for female SLE patients in the Oklahoma Cohort of Rheumatic Disease (OCRD) by county (n=689). Geographic and lifestyle exposure data were sourced from the 2020 County Health Rankings and the 2020 National Environmental Public Health Tracking Network. Explanatory variables explored included the percentage of smokers, percentage of high school graduates, percentage of rural residents, PM2.5 (atmospheric particulate matter < 2.5 um in diameter), primary care physicians per 100,000 population, silica sites, superfund sites, percentage of uninsured adults, and solar irradiance (kJ/m2). Spatial autocorrelation was assessed using a Moran’s I test, which was insignificant (p=0.7205). Therefore, a multiple linear regression model was used to analyze the explanatory variables with SLE rates, and the model with the lowest AIC was chosen. Log transformations were applied to variables exhibiting a right skewness.

Results: The OCRD includes between 1 and 161 per 100,000 individuals from each of 44 counties in Oklahoma (Figure 1). No associations between county-specific environmental exposures and numbers of female SLE patients in the cohort were observed. However, percentages of high school graduates and the percentage of rural residents were negatively associated and solar irradiance was positively associated with numbers of SLE patients in the cohort (Table 1).

Conclusion: Environmental and lifestyle exposures do not seem to affect membership of female SLE patients in the Oklahoma Cohort of Rheumatic Diseases. The cohort is drawing greater numbers of SLE patients from counties with fewer high school graduates, less rural population and a higher UV index. The study is limited in that it is not an incidence or prevalence calculation for SLE, although factors affecting cohort membership, other than distance, may be similar throughout Oklahoma. Further direct comparison of individuals identified from relevant counties may help to determine whether exposure variables are associated with disease severity or cumulative disease activity.

Supporting image 1

Figure 1: Systemic Lupus Erythematosus (SLE) Rates of Females from the Oklahoma Cohort of Rheumatic Disease (OCRD) Cohort by County 2004_2023

Supporting image 2

Table 1: Multiple Linear Regression Model for Explanatory Variables of SLE Rates


Disclosures: Z. Reed: None; J. Campbell: None; X. Howard: None; T. Aberle: None; B. Parrish: None; W. DeJager: None; C. Arriens: AstraZeneca, 1, 5, 6, Aurinia, 1, 6, Bristol-Myers Squibb(BMS), 1, 5, Cabaletta, 1, GlaxoSmithKlein(GSK), 1, Kezar, 1, Synthekine, 1, UCB, 1; J. Merrill: AbbVie, 1, 2, Alexion, 1, 2, Alumis, 1, 2, Amgen, 1, 2, AstraZeneca, 1, 2, 5, Aurinia, 1, 2, Bristol Myers Squibb, 1, 2, 5, EMD Serono, 1, 2, Genentech, 1, 2, Gilead, 1, 2, GlaxoSmithKline, 1, 2, 5, Kezar, 1, 2, Lilly, 1, 2, Merck, 1, 2, Pfizer, 1, 2, Provention, 1, 2, Remegen, 1, 2, Sanofi, 1, 2, Takeda, 1, 2, UCB, 1, 2, Zenas, 1, 2; J. James: GlaxoSmithKlein(GSK), 1, Progentec Diagnostics, Inc., 5, 10.

To cite this abstract in AMA style:

Reed Z, Campbell J, Howard X, Aberle T, Parrish B, DeJager W, Arriens C, Merrill J, James J. Geographic and Lifestyle Exposures in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/geographic-and-lifestyle-exposures-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/geographic-and-lifestyle-exposures-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology